Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
102.80    -1.40 (-1.34%)
Bid:
102.20
Ask:
103.20
Spread: 1.00 (0.978%)
Market Cap: £432.12m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Director/PDMR Shareholding

3 Feb 2010 18:00

RNS Number : 6546G
PZ CUSSONS PLC
03 February 2010
 



PZ Cussons Plc (the "Company")

Announcement regarding dealing in shares

This notification is made in accordance with DR 3.1.4R(1)(a).

On 3 February 2010 Mr A Kanellis exercised options granted to him under the Company's Executive Share Option Scheme ("the ESOS") over 313,799 ordinary shares of 1p in the Company at the following exercise prices:

214,010 shares at £0.747 per share

99,789 shares at £1.104 per share

He subsequently sold 179,558 ordinary shares to the Paterson Zochonis Employee Trust ("the Trust") on 3 February for a consideration of £2.5480 per share. Mr Kanellis is Chief Executive of the Company and the Company was informed by Mr Kanellis of this dealing on 3 February. After this sale, Mr Kanellis holds 262,239 ordinary shares in the Company (comprising 0.06% of the total shares in issue).

 

On 3 February 2010 Mr C Davis exercised options granted to him under the Company's Executive Share Option Scheme over 242,040 ordinary shares of 1p in the Company at the following exercise prices:

76,900 shares at £0.747 per share

31,170 shares at £1.104 per share

 

62,900 shares at £1.298 per share

 

71,070 shares at £1.407 per share

 

He subsequently sold 242,040 ordinary shares to the Trust on 3 February for a consideration of £2.5480 per share. Mr Davis is Commercial Director of the Company and the Company was informed by Mr Davis of this dealing on 3 February. After this sale, Mr Davis holds 170,761 ordinary shares in the Company (comprising 0.04% of the total shares in issue).

The Trust is a discretionary trust under which the class of beneficiaries who may benefit comprises all bona fide employees and former employees of the Company and its subsidiaries including members of such employees' and former employees' immediate families. Accordingly, the Executive Directors and PDMRs of the Company are included in the class of beneficiaries and are deemed to have an interest in all of such shares. The Trust's holding in the ordinary shares of 1p in the Company after the dealings listed above is 1,122,496 shares (0.26%).

 

On 1 February 2010 Mr Chris How, who has been designated by the Board of the Directors of the Company as a person discharging managerial responsibility, sold 15,000 ordinary shares for a consideration of £2.45 per share. After this sale, Mr How holds 39,509 ordinary shares in the Company (comprising less than 0.01% of the total shares in issue). The Company was informed by Mr How of this dealing in shares on 1 February.

 

No new shares have been issued in respect of any of the dealings above. The current issued share capital of the company is 428,724,960 ordinary shares of 1p each.

Name of contact and telephone number for queries:

Sam Plant, Company Secretary, PZ Cussons Plc, (T) (00) 44 (0)161 491 8000

Date: 3 February 2010

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSTJMRTMBAMBRM
Date   Source Headline
21st Nov 20245:03 pmRNSResult of AGM
21st Nov 20247:00 amRNSAGM Trading Statement
20th Nov 20241:36 pmRNSDirector/PDMR Shareholding
21st Oct 20249:21 amRNSDirector/PDMR Shareholding
27th Sep 20241:16 pmRNSDirector/PDMR Shareholding
27th Sep 20241:11 pmRNSDirector/PDMR Shareholding
26th Sep 20244:09 pmRNSPublication of Annual Report and Notice of AGM
25th Sep 20245:48 pmRNSDirector/PDMR Shareholding
25th Sep 202410:40 amRNSDirector Declaration
19th Sep 20245:36 pmRNSDirector/PDMR Shareholding
18th Sep 20247:22 amRNSBoard Change
21st Aug 20244:29 pmRNSDirector/PDMR Shareholding
25th Jul 202411:10 amRNSDirector/PDMR Shareholding
19th Jul 20245:31 pmRNSDirector/PDMR Shareholding
26th Jun 20247:00 amRNSTrading Statement
25th Jun 20249:39 amRNSDirector/PDMR Shareholding
20th May 202411:52 amRNSDirector/PDMR Shareholding
10th May 202410:00 amRNS2023 AGM Voting Results Update Statement
24th Apr 20247:00 amRNSQ3 Trading and update on strategic actions
19th Apr 20248:49 amRNSDirector/PDMR Shareholding
12th Apr 202411:04 amRNSDirector/PDMR Shareholding
8th Apr 20245:29 pmRNSDirector/PDMR Shareholding
19th Mar 202410:30 amRNSDirector/PDMR Shareholding
23rd Feb 20243:47 pmRNSDirector/PDMR Shareholding
19th Feb 20243:18 pmRNSDirector/PDMR Shareholding
8th Feb 20243:40 pmRNSDirector/PDMR Shareholding
8th Feb 20243:09 pmRNSDirector/PDMR Shareholding
8th Feb 20243:07 pmRNSDirector/PDMR Shareholding
7th Feb 20247:00 amRNS2024 Interim Results
19th Jan 202410:50 amRNSDirector/PDMR Shareholding
15th Jan 20247:00 amRNSDirectorate Change
18th Dec 20233:10 pmRNSDirector/PDMR Shareholding
4th Dec 20233:03 pmRNSDirector/PDMR Shareholding
4th Dec 20237:00 amRNSDirectorate Change
29th Nov 202312:10 pmRNSDirector/PDMR Shareholding
29th Nov 202312:08 pmRNSDirector/PDMR Shareholding
23rd Nov 20235:57 pmRNSResult of AGM
23rd Nov 20237:00 amRNSAGM Trading Statement
20th Nov 20231:58 pmRNSDirector/PDMR Shareholding
19th Oct 202310:00 amRNSDirector/PDMR Shareholding
10th Oct 202311:10 amRNSDirector/PDMR Shareholding
5th Oct 20233:44 pmRNSHolding(s) in Company
27th Sep 202310:00 amRNSPreliminary Results - Correction
26th Sep 20237:00 amRNSPZ Cussons Preliminary Results
20th Sep 202311:09 amRNSDirector/PDMR Shareholding
5th Sep 20237:00 amRNSAcquisition of minority ownership of PZCN Plc
21st Aug 20232:07 pmRNSDirector/PDMR Shareholding
26th Jul 20239:22 amRNSDirector/PDMR Shareholding
19th Jul 202310:23 amRNSDirector/PDMR Shareholding
11th Jul 20232:06 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.